Spotlight on Camrelizumab in Advanced Squamous Lung Cancer: Another Feather in the Cap of Chinese Checkpoint Inhibitors

J Thorac Oncol. 2022 Apr;17(4):477-480. doi: 10.1016/j.jtho.2022.01.001.

¹ Department of Medical Oncology, Thoracic Oncology Unit, Hospital Clinic, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain. Electronic address: nreguart@clinic.cat.
² Department of Medical Oncology, Thoracic Oncology Unit, Hospital Clinic, Barcelona, Spain; Translational Genomics and Targeted Therapies in Solid Tumors, IDIBAPS, Barcelona, Spain.

No abstract available

Publication types